Congress

ESH CLL 2024

8 Mar - 10 Mar 2024Vienna, Austria
European School of Haematology - Chronic Lymphocytic Leukemia

Did you miss us at the ESH 3rd Translational Research Conference: Chronic Lymphocytic Leukaemia?

If so, you can chat with a member of our team by clicking the ‘Chat with BeiGene’ icon.

Did you attend our Satellite Symposium: New avenues to improving outcomes for CLL patients?

If not, you are lucky, you can view the webcast of the Satellite Symposium here.

The Satellite Symposium, titled ‘New avenues to improving outcomes for CLL patients’, provided an overview of BTK inhibitors in TN and R/R CLL, with a focus on biomarkers and treatment selection. The experts discussed BTK mutation data and ways to overcome resistance to current CLL treatments. New translational data and latest results from the German Richter’s transformation RT1 study were also presented.

Add to your calendar (ICS)